Perfluorocarbon emulsions as a promising technology: A review of tissue and vascular gas dynamics

Journal of Applied Physiology

Volumn 106, Issue 4, 2009, Pages 1444-1452

  Spiess, Bruce D ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VCUHS   (United States)

Author keywords

Decompression sickness; Gas embolism; Oxycyte; Oxygen delivery

Indexed keywords

BLOOD SUBSTITUTE; FLUOROCARBON; NITROGEN;

ARTERY EMBOLISM; DECOMPRESSION SICKNESS; EMULSION; ERYTHROCYTE MEMBRANE; GAS EMBOLISM; NONHUMAN; OXYGEN THERAPY; PRIORITY JOURNAL; REVIEW; VASCULARIZATION; VEIN EMBOLISM; AIR EMBOLISM; ANIMAL; DIVING; ENVIRONMENT; GAS; HUMAN; HYPERBARIC OXYGEN; METABOLISM; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DECOMPRESSION SICKNESS; DIVING; EMBOLISM, AIR; EMULSIONS; ENVIRONMENT; FLUOROCARBONS; GASES; HUMANS; HYPERBARIC OXYGENATION; NITROGEN; OXYGEN CONSUMPTION;

EID: 66149114779     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.90995.2008     Document Type: Review

References (80)

1. Aleksandrin VV, Kozhura VL, Novoderzhkina IS, Moroz VV. [Effect of Perftoran on cerebral blood flow in the reperfusion period after global transient brain ischemia] (in Russian). Anestheziol Reanimatol 6: 50-52, 2003.
2. Arnold JV, Wagner D, Fleming J, Bird AC, Grossbard E, Kaufman R, Taylor RM. Cerebral protection during cardiopulmonary bypass using perfluorocarbons: a preliminary report. Perfusion 8: 249-274, 1993.
3. 2, lactate, and acid exchange during contractions and recovery. J Appl Physiol 54: 1687-1692, 1983.
4. Bell RD, Frazer GD, Brock DG, Strause J, Powers BL, Pelura TJ, Kramer MS, Osterholm JL. Reduction of cerebral infarction using the third circulation. Crit Care Med 30: 2684-2688, 2002. (Pubitemid 36870570)
5. Bell RD, Frazer GD, Osterholm JL, Duckett SW. A novel treatment for ischemic intracranial hypertension in cats. Stroke 22: 80-83, 1991.
6. Bose B, Osterholm JL, Payne JB, Chambers K. Preservation of neural function during prolonged focal cerebral ischemia by ventriculocisternal perfusion with oxygenated fluorocarbon emulsion. Neurosurgery 18: 270-276, 1986. (Pubitemid 16139379)
7. Breuninger HG, Rubenstein SD, Wolfson MR, Shaffer TH. Effect of exchange transfusion with red cell substitution on neonatal hemodynamics and organ blood flows. J Pediatr Surg 28: 144-150, 1993.
8. Clark LC. Emulsion of perfluoronated solvents for intravenous gas transport. Fed Proc 34: 1468-1477, 1981.
9. Clark LC, Becattini F, Kaplan S. The physiological effects of artificial blood made from inert organic solvents. Ala J Med Sci 9: 16-29, 1972.
10. Cochran RP, Kunzelman KS, Vocelka CR, Akimoto H, Thomas R, Soltow LO, Spiess BD. Perfluorocarbon emulsion in cardiopulmonary bypass prime reduces neurologic injury. Ann Thorac Surg 63: 1326-1332, 1997. (Pubitemid 27239723)
11. Dainer H, Nelson J, Brass K, Montcalm-Smith E, Mahon R. Short oxygen pre-breathing and intravenous perfluorocarbon emulsion reduces morbidity and mortality in a swine saturation model of decompression sickness. J Appl Physiol 102: 1099-1104, 2007. (Pubitemid 46377037)
12. Daugherty WP, Levasseur JE, Sun D, Spiess BD, Bullock MR. Per- fluorocarbon emulsion improves cerebral oxygenation and mitochondrial function after fluid percussion brain injury in rats. Neurosurgery 54: 1223-1230, 2004. (Pubitemid 38585938)
13. Doolette DJ, Upton RN, Martinez AM. Brain pharmacokinetics of lignocaine before and following intravenous perfluorocarbon emulsion infusion in sheep. Clin Exp Pharmacol Physiol 32: 367-371, 2005.
14. Dromsky DM, Spiess BD, Falman A. Treatment of decompression sickness in swine with intravenous perfluorocarbon emulsion. Aviat Space Environ Med 75: 301-305, 2004.
15. Eckmann DM, Armstead SC. Influence of endothelial glycocalyx degredation and surfactants on air embolism adhesion. Anesthesiology 105: 1220-1227, 2006.
16. Eckmann DM, Lomivortov VN. Microvascular gas embolization clearance following perfluorocarbon administration. J Appl Physiol 94: 860-868, 2003.
17. Eggleton CD, Tuhin KR, Popel AS. Predictions of capillary oxygen transport in the presence of fluorocarbon additives. Am J Physiol Heart Circ Physiol 275: H2250-H2257, 1998.
18. Faithfull NS, Weers JG. Perfluorocarbon compounds. Vox Sang 74: 243-248, 1998.
19. Gale SC, Gorman GD, Copeland JG, McDonaugh PF. Perflubron emulsion prevents PMN activation and improves myocardial functional recovery after cold ischemia and reperfusion. J Surg Res 138: 135-140, 2007.
20. Geyer RP. Substitutes for blood and its components. Prog Clin Biol Res 19: 1-26, 1978.
21. Geyer RP. "Bloodless" rats throught the use of artificial blood substitutes. Fed Proc 34: 1499-1505, 1975.
22. Geyer RP. Fluorocarbon-polyol artificial blood substitutes. N Engl J Med 289: 1077-1082, 1973.
23. Geyer RP. Oxygen transport in vivo by means of perfluorochemical preparations. N Engl J Med 307: 304-305, 1982.
24. Gould SA, Rosen AL, Sehgal LR, Langdale LA, Krause LM, Rice CL, Chamberlin WH, Moss GS. Fluosol-DA as a red cell substitute in acute anemia. N Engl J Med 314: 1653-1656, 1986.
25. Greenspan JS, Wolfson MR, Shaffer TH. Liquid ventilation. Semin Perinatol 24: 396-405, 2000.
26. Hellums JD. The resistance to oxygen transport in capillaries relative to that in the surrounding tissue. Microvasc Res 13: 131-139, 1977.
27. Herren JI, Kunzelman KS, Vocelka C, Cochran RP, Spiess BD. Angiographic and histological evaluation of porcine retinal vascular damage and protection with perfluorocarbons after massive air embolism. Stroke 1998; 29: 2396-2403 (Pubitemid 28511964)
28. Herren JI, Kunzelman KS, Vocelka C, Cochran RP, Spiess BD. Horseradish peroxidase as a histological indicator of mechanisms of porcine retinal vascular damage and protection with perfluorocarbons after massive air embolism. Stroke 28: 2025-2030, 1997. (Pubitemid 27459014)
29. Hills BA, LeMessurier DH. Unsaturation in living tissue relative to the pressure and composition of inhaled gas and its significance in decompression theory. Clin Sci 36: 185-195, 1969.
30. 2 delivery in canine gastrocnemius muscle in situ. J Appl Physiol 66: 1219-1226, 1989.
31. 2 solubility improves uptake of in situ dog muscle working maximally. J Appl Physiol 73: 2470-2475, 1992.
32. Homer LD, Weathersby PK, Kiesow LA. Oxygen gradients between red cells in the microcirculation. Microvasc Res 22: 308-323, 1981.
33. Jeng MJ, Yang SS, Hwang B, Wolfson MR, Shaffer TH. Effects of perfluorochemical evaporation properties on oxygenation during partial liquid ventilation. Pediatr Int 48: 608-615, 2006.
34. Kerins DM. Role of perfluorocarbon Fluosol-DA in coronary angioplasty. Am J Med Sci 307: 218-221, 1994.
35. Kline RA, Negendank W, McCoy L, Berguer R. Beneficial effects of isovolemic hemodilution using a perfluorocarbon emulsion in a stroke model. Am J Surg 162: 103-106, 1991.
36. Kline RA, Negendank W, McCoy LE. Treatment of cerebral ischemia with dextran-40 or fluosol DA-20%. Biomater Artif Cells Immobilization Biotechnol; 20: 979-983, 1992.
37. Kolluri S, Heros RC, Hedley-Whyte ET, Vonsattel JP, Miller D, Zervas NT. Comparison of the effect of fluosol DA and dextran 40 on regional cerebral blood flow, infarction size and mortality in cats with temporary occlusion of the middle cerebral artery. Surg Neurol 26: 3-8, 1986. (Pubitemid 16065317)
38. Kolluri S, Heros RC, Hedley-Whyte ET, Vonsattel JP, Miller D, Zervas NT. Effect of Fluosol on oxygen availability, regional cerebral blood flow, and infarct size in a model of temporary focal cerebral ischemia. Stroke 17: 976-980, 1986. (Pubitemid 16000741)
39. Kwon TH, Sun D, Daugherty WP, Spiess BD, Bullock MR. Effects of perfluorocarbons on brain oxygenation and ischemic damage in an acute subdural hematoma model in rats. J Neruosurg 103: 724-730, 2005. (Pubitemid 43193881)
40. Laycock JR, Coakham HB, Silver IA, Walters FJ. Effect of carotid artery ligation and infusion of fluosol FC-43 emulsion on brain surface oxygen tensions. Stroke 17: 1242-1246, 1986.
41. Lowe KC. Engineering blood: synthetic substitutes from fluorinated compounds. Tissue Eng 9: 389-399, 2003.
42. Lundgren C, Bergoe G, Olszowka A, Tyssebotn I. Tissue nitrogen elimination in oxygen-breathing pigs is enhanced by fluorocarbon-derived intravascular microbubbles. Undersea Hyperb Med 32: 215-226, 2005. (Pubitemid 41323149)
43. Lynch PR, Krasenr LJ, Vincinquerra T, Shaffer TH. Effects of intravenous perfluorocarbon and oxygen breathing on acute decompression sickness in the hamster. Undersea Biomed Res 16: 275-281, 1989.
44. Mahon RT, Dainer HM, Nelson JW. Decompression sickness in a swine model: isobaric denitrogenation and perfluorocarbon at depth. Aviat Space Environ Med 77: 8-12, 2006.
45. Marsh JN, Senpan A, Hu G, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomed 2: 533-543, 2007. (Pubitemid 47365128)
46. Mutsuno T, Ohyanagi H, Naito R. clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA): summary of 186 cases. Ann Surg 195: 60-69, 1982. (Pubitemid 12194945)
47. Novotny JA, Bridgewater BM, Himm JF, Homer LD. Quantifying the effect of intravascular perfluorocarbon on xenon elimination from canine muscle. J Appl Physiol 74: 1356-1360, 1993.
48. O'Brien RN, Langlais AJ, Deufert WD. Diffusion coefficients of respiratory gases in a perfluorocarbon liquid. Science 217: 153-155, 1982.
49. Obraztsov VV, Neslund GG, Kornbrust ES, Flaim SF, Woods CM. In vitor cellular effects of perfluorochemicals correlate with their cellular lipid solubility. Am J Physiol Lung Cell Mol Physiol 278: L1018-L1024, 2000.
50. Padnick LB, Linsenmeier RA, Goldstick TK. Perfluorocarbon emulsion improves oxygenation of the cat primary visual cortex. J Appl Physiol 86: 1497-1504, 1999.
51. Peerless SJ, Nakamura R, Rodriguez-Salazar A, Hunter IG. Modification of cerebral ischemia with Fluosol. Stroke 16: 38-43, 1985. (Pubitemid 15194754)
52. Pereira BM, Weinstein PR, Rodriguez y Baena R. Effects of treatment with fluosol and mannitol during temporary middle cerebral artery occlusion in cats. Neurosurgery 23: 139-142, 1988.
53. Popel AS. Theory of oxygen transport to tissue. Crit Rev Biomed Eng 17: 257-321, 1989.
54. Rafinkova O, Sokolova E, Rafikov R, Nudler E. Control of plasma nitric oxide bioactivity by perfluorocarbons: physiological mechanisms and clinical implications. Circulation 110: 3573-3580, 2004. (Pubitemid 39612573)
55. Rosen AL, Sehgal LR, Gould SA, Sehgal H, Dalton L, Rice CL, Moss GS. Fluorocarbon emulsions: methodology to assess efficacy. Crit Care Med 10: 149-154, 1982.
56. Rousou JA, Engleman RM, Anisimowicz L, Dobbs WA. A comparison of blood and Fluosol-DA for cardiopulmonary bypass. J Cardiovasc Surg (Torino) 26: 447-453, 1985. (Pubitemid 15017602)
57. Sakas DE, Crowell RM, Kim K, Korosue K, Zervas NT. The perfluorocarbon fluoromethyloadmantane offers cerebral protection in a model of isovolemic hemodilution in rabbits. Stroke 25: 197-201, 1994. (Pubitemid 24977203)
58. Sashikant BN, Miller TL, Jeng MJ, Davis J, Shaffer TH, Wolfson MR. Differential impact of perfluorochemical physical properties on the physiologic, histologic and inflammatory profile in acute lung injury. Crit Care Med 33: 1096-1103, 2005. (Pubitemid 40638185)
59. Schroeder JL, Highsmith JM, Young HF, Mathern BE. Reduction of hypoxia by perfluorocarbon emulsion in a traumatic spinal cord injury model. J Neurosurg Spine 9: 213-220, 2008.
60. Sloviter HA, Petrovic M, Ogoshi S, Yamada H. Dispersed fluorochemicals as substitutes for erythrocytes in intact animals. J Appl Physiol 27: 666-668, 1969.
61. 60a. Smith CR. Intravenous Administration of Perfluorocarbon Emulsions as a Non-Recompression Therapy for Decompression Sickness (PhD dissertation). Virginia Commonwealth Univ., 2008.
62. Spahn DR, Van Brempt R, Theilmeier G, Reibold JP, Welte M, Heinzerling H, Birck KM, Keipert PE, Messmer K, Heinzerling H, Birck KM, Keipert PE, Messmer K. Perflubron emulsion delays blood transfusions in orthopedic surgery. Anesthesiology 91: 1195-1208, 1999. (Pubitemid 29506080)
63. Spahn DR, Waschke KF, Standl T, Motsch J, Van Huynegem L, Welte M, Gombotz H, Coriat P, Verkh L, Faithfull S, Keipert P; European Perflubron Emulsion in Non-Cardiac Surgery Study Group. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study. Anesthesiology 97: 1338-1349, 2002.
64. Spiess BD, Braverman B, Woronowicz AW, Ivankovich AD. Protection from cerebral air emboli with perfluorocarbons in rabbits. Stroke 17: 1146-1149, 1986. (Pubitemid 17008945)
65. Spiess BD, Cochran RP. Perfluorocarbon emulsions and cardiopulmonary bypass: a technique for the future. J Cardiothorac Vasc Anesth 10: 83-90, 1996.
66. Spiess BD, McCarthy R, Piotrowski D, Ivankovich AD. Protection from venous air embolism with fluorocarbon emulsion FC-43. J Surg Res 41: 439-444, 1986. (Pubitemid 17179676)
67. Spiess BD, McCarthy RJ, Tuman KJ, Woronowicz AW, Tool KA, Ivankovich AD. Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43). Undersea Biomed Res 15: 31-37, 1988.
68. Spiess BD, McCarthy RJ, Tuman KJ, Ivankovich AD. Protection from coronary air embolism by a perfluorocarbon emulsion (FC-43). J Cardiothorac Anesth 1: 210-215, 1987.
69. Sutherland GR, Farrar JK, Peerless SJ. the effect of Fluosol DA on oxygen availability in focal cerebral ischemia. Stroke 15: 829-835, 1984.
70. Suzuki J, Fujimoto S, Mizoi K, Oba M. The protective effect of combined administration of anti-oxidants and perfluorochemicals on cerebral ischemia. Stroke 15: 672-679, 1984. (Pubitemid 14090243)
71. Symons JD, Sun X, Flaim SF, del Balzo U. Perflubron emulsion improves tolerance to low-flow ischemia in isolated rabbit hearts. J Cardiovasc Pharmacol 34: 108-115, 1999. (Pubitemid 29296145)
72. 2 availability and computerized EEG data during cerebral ischemia. Neurol Res 12: 17-22, 1990.
73. Tremper KK, Friedman AE, Levine EM, Lapin R, Camarillo D. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med 307: 277-283, 1982.
74. Wakabayashi T, Tamura M, Nakamura T. Partial liquid ventilation with low-dose perfluorochemical and high-frequency oscillation improves oxygenation and lung compliance in a rabbit model of surfactant depletion. Biol Neonate 89: 177-182, 2006.
75. Ward KR, Torres Filho I. Oxygen transport monitoring: the basis for developing transfusion triggers. In: Perioperative Transfusion Medicine, edited by Spiess, BD, Spence R, Shander AE. Baltimore, MD: Lippincott, Williams and Wilkins, 2006, chapt. 5, p. 55-66.
76. Wardley-Smith B, Hadley MJ. Recent molecular theories of general anaesthesia. Br J Anaesth 51: 619-626, 1979. (Pubitemid 10247941)
77. Woitzik J, Weinzierl N, Schilling L. Early administration of a second-generation perfluorochemcial decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat. Neurol Res 27: 509-515, 2005. (Pubitemid 41040838)
78. Wolfson MR, Shaffer TH. Pulmonary applications of perfluorochemical liquids, ventilation and beyond. Paediatr Respir Rev 6: 117-127, 2005.
79. Yoshitani K, deLange F, Ma Q, Grocott HP, MacKensen GB. Reduction in air bubble size using perfluorocarbons during cardiopulmonary bypass in the rat. Anesth Analg 103: 1089-1093, 2006.
80. Zhu J, Hullett JB, Somera L, Barbee RW, Ward KR, Berger BE, Spiess BD. Intravenous perfluorocarbon emulsion increases nitrogen washout after venous gas emboli in rabbits. Undersea Hyperb Med 34: 7-20, 2007.